Skip to Main Content

(2399) A single arm, openlabel, multicenter study evaluating the longterm safety, tolerability and efficacy of 0.5 mg fingolimod (FTY720) administered orally once daily in patients with multiple sclerosis

Principal Investigator

Silvia Delgado

Clinical Trial ID

Institutional Protocol # 20111162

Clinical Trial Summary


Phase

Phase III


Funding Agency/Sponsor

Industry


Disease

Multiple Sclerosis



Contact Information

Study Contact Neurology Research
Phone Number 1-877-977-7724